| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Molecular Neurobiology, Brain Research Institute, and the 2Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
PURPOSE. This study sought to elucidate changes in the levels and distribution of brain-derived neurotrophic factor (BDNF) in the retina throughout aging and depending on visual experience.
METHODS. Protein and mRNA levels of BDNF were quantified by enzyme-linked immunosorbent assay (ELISA) and semiquantitative reverse transcription–polymerase chain reaction (RT-PCR), respectively. Levels were assayed in the retinas of rats on postnatal day (P)2, P7, and P14 (approximate time of eye opening) and at 1 month (M), 3M, 8M, and 18M of age. Changes in BDNF expression and localization in the retina were assessed by immunohistochemistry. The effect of monocular deprivation during infancy on retinal BDNF expression was also examined, by ELISA and immunohistochemistry.
RESULTS. Both protein and mRNA levels of BDNF in the rat retina increased after P14. Immunohistochemical analyses revealed that the increase in BDNF protein levels occurred in retinal ganglion cells (RGCs) between P14 and 1M. BDNF immunoreactivity in Müller cell processes was observed in the inner nuclear layer at 1M, but not at P14. The levels of BDNF protein in the retinas of visually deprived eyes were lower than those of control eyes, as quantified by ELISA. Immunohistochemistry showed that BDNF immunoreactivity in RGCs was diminished by visual deprivation, whereas Müller cells were unaffected.
CONCLUSIONS. These observations indicate that BDNF expression in RGCs is upregulated in an activity-dependent manner, whereas that in Müller cells is regulated only by development.
This article has been cited by other articles:
|
|
 |
|
  X. Liu, R. N. Grishanin, R. J. Tolwani, R. C. Renteria, B. Xu, L. F. Reichardt, and D. R. Copenhagen Brain-Derived Neurotrophic Factor and TrkB Modulate Visual Experience-Dependent Refinement of Neuronal Pathways in Retina J. Neurosci., July 4, 2007; 27(27): 7256 - 7267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Joly, V. Pernet, S. Chemtob, A. Di Polo, and P. Lachapelle Neuroprotection in the Juvenile Rat Model of Light-Induced Retinopathy: Evidence Suggesting a Role for FGF-2 and CNTF Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2311 - 2320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Lupien and C. Salesse Characterization of Two Spontaneously Generated Human Muller Cell Lines from Donors with Type 1 and Type 2 Diabetes Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 874 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Landi, A. Sale, N. Berardi, A. Viegi, L. Maffei, and M. C. Cenni Retinal functional development is sensitive to environmental enrichment: a role for BDNF FASEB J, January 1, 2007; 21(1): 130 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Seki, T Tanaka, H Matsuda, T Togano, K Hashimoto, J Ueda, T Fukuchi, and H Abe Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model Br. J. Ophthalmol., April 1, 2005; 89(4): 504 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Seki, T. Tanaka, H. Nawa, T. Usui, T. Fukuchi, K. Ikeda, H. Abe, and N. Takei Involvement of Brain-Derived Neurotrophic Factor in Early Retinal Neuropathy of Streptozotocin-Induced Diabetes in Rats: Therapeutic Potential of Brain-Derived Neurotrophic Factor for Dopaminergic Amacrine Cells Diabetes, September 1, 2004; 53(9): 2412 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu and N. Tian Pathway-Specific Maturation, Visual Deprivation, and Development of Retinal Pathway Neuroscientist, August 1, 2004; 10(4): 337 - 346. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
